Change Text Size
Email Columns Print page
Columns: The Online newspaper for the University of Georgia community
Magnify He, Biao-h.portrait2
Biao He

Vaccine researcher appointed to Davison Chair

Carolyn Crist

Graduate Assistant

Recent and archived articles by Carolyn Crist


College of Veterinary Medicine
By Carolyn Crist |
May 19, 2014
Share    

Biao He, a renowned veterinary virologist and vaccine developer, has been appointed to the Fred C. Davison Distinguished University Chair in Veterinary Medicine.

He, a Georgia Research Alliance Distinguished Investigator and professor in the College of Veterinary Medicine's infectious diseases department, is known for his research on host-viral pathogen interactions and anti-viral vaccine development. His laboratory focuses on defining viral pathogenesis at the molecular level and asking how viral proteins overcome host defense.

Vaccine researcher appointed to Davison Chair

He also collaborates with a large number of infectious disease researchers at UGA to examine the efficacy of using a nonpathogenic parainfluenza virus as a vaccine against a variety of viral and other disease agents including HIV, influenza, tuberculosis, malaria and as a novel anti-cancer therapy.

"Dr. He actively collaborates with many other investigators in the college and university, which is the fundamental objective for this endowed chair position," said Sheila W. Allen, dean of the college. "Dr. He works with faculty in the basic and clinical sciences to help them better understand the nature of disease processes so that novel therapies can be developed."

He earned a doctorate in microbiology and immunology from the State University of New York Downstate Medical Center in 1996. He served as an assistant and then associate professor of veterinary and biomedical sciences at Pennsylvania State University before coming to UGA in 2009.

"Dr. He is the perfect choice for the Davison Chair. His collaborative nature and research programs are the essence of what this position was designed for," said Fred Quinn, head of the college's infectious diseases department. "Dr. He is an extraordinary scientist and entrepreneur. His work, particularly in the area of vaccine development against emerging and zoonotic infectious diseases, will enhance our research reputation and provide a translational platform for the control of numerous problematic human and animal disease agents."

View as single page

More from this issue

FOR MORE ONLINE
UGA Twitter Facebook RSS
Columns is produced by the University of Georgia Public Affairs Division | Feedback